WilliamSikovMD
Oncology • Providence, RIBreast Cancer, Gastrointestinal Cancer, Hematologic Oncology
Associate Professor of Medicine, Brown University
Dr. Sikov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 Dudley St
Providence, RI 02905Phone+1 401-453-7540Fax+1 401-453-7785- Is this information wrong?
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
UPMC Medical EducationResidency, Internal Medicine, 1982 - 1985
Yale School of MedicineClass of 1982
Certifications & Licensure
MA State Medical License 1986 - 2025
RI State Medical License 1989 - 2024
PA State Medical License 1983 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse Start of enrollment: 2007 Nov 01
- Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer Start of enrollment: 2008 Feb 01
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 15
- Join now to see all
Publications & Presentations
PubMed
- Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.Smith, K., Zhao, F., Mayer, I., Tevaarwerk, A., Garcia, S., Arteaga, C., Symmans, W., Park, B., Burnette, B., Makower, D., Block, M., Morley, K., Jani, C., Mescher, C....> ;Cancer. 2024 Jan 18
- 4 citationsAKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.Maysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis, Elisa Baldelli, Emna El Gazzah, Frances Valdes, William M Sikov, Monica M Mita, Neelima Denduluri, Rita Murphy, Dani...> ;NPJ Precision Oncology. 2023 Feb 16
- Reply to the Letter to the Editor 'Risk of MDS/AML with the addition of neoadjuvant carboplatin to standard chemotherapy for triple-negative breast cancer' by A. Okine...C E Geyer Jr, W M Sikov, S Loibl> ;Annals of Oncology. 2022 Jul 1
- Join now to see all
Journal Articles
- Association of Immunophenotype with Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast CancerCharles E Geyer, William M Sikov, JAMA Oncology
Lectures
- CALGB (Alliance) 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) and bevacizumab (Bev) in triple-negative breast cancer (TN...2019 ASCO Annual Meeting - 6/1/2019
Other
- Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosisSikov WM
http://www.uptodate.com/contents/neoadjuvant-systemic-therapy-for-breast-cancer-response-subsequent-
UpToDate, Wolters Kluwer Health - 2013-03-20 - Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic optionsSikov WM, Wolff AC
http://www.uptodate.com/contents/neoadjuvant-therapy-for-breast-cancer-rationale-pretreatment-evalua
UpToDate, Wolters Kluwer Health - 2012-09-17
Press Mentions
Women & Infants Doctor to Appear on ‘Jeopardy!’September 26th, 2019
Adjuvant Pertuzumab in HER2-Positive Breast Cancer: Value yet to Be DemonstratedOctober 10th, 2017
Pathologic Complete Response Best Predictor in Triple-Negative PrognosisFebruary 10th, 2016- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Miriam HospitalProvidence, Rhode Island
Rhode Island HospitalProvidence, Rhode Island
Women & Infants Hospital of Rhode IslandProvidence, Rhode Island
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
